17th Oct 2007 08:46
Assura Group Limited17 October 2007 Assura Group Limited ("Assura" or the "Company") Issue of equity The Company today announces that it has completed the acquisition of CystoscopeHire Ltd and Urosonics Ltd. Both companies provide portable clinical equipmentunder contract to consultants and hospitals across London. These companies willbe integral to Assura Diagnostics Limited, a new venture in which Assura has an80 per cent financial interest. Consideration is in the form of 750,000 newordinary shares of 10 pence each in the capital of Assura (the "ConsiderationShares"). Application has been made to the UK Listing Authority for admissionof the Consideration Shares to the Official List and to the London StockExchange for admission to trading. It is expected that the admission will becomeeffective and dealings in such shares will commence on or around 18 October2007. The Consideration Shares will be subject to a lock up with respect to50% until 31 March 2009 and 50% with respect to 31 March 2011. Assura Diagnostics will develop clinical equipment solutions for primary andsecondary care customers and will work closely with Assura Medical to developservices that will support the government's aim of shifting care closer to thepatient. Following admission of the Consideration Shares, the total number of 10 penceordinary shares in the capital of the Company with voting rights will be235,213,115. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Assura